MARC details
000 -LEADER |
fixed length control field |
04101cam a2200409 i 4500 |
001 - CONTROL NUMBER |
control field |
1246352787 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231113131601.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210417t20222022mdu b 001 0 eng c |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2021007377 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781585287000 |
Qualifying information |
(paperback) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
.b107322560 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1246352787 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
YDX |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
YDX |
Modifying agency |
VRC |
-- |
UAB |
-- |
OCLCF |
-- |
UtOrBLW |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
OS2A |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM301.5 |
Item number |
C587 2022 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Murphy, John E., |
Dates associated with a name |
1945- |
Relator term |
editor. |
245 00 - TITLE STATEMENT |
Title |
Clinical pharmacokinetics / |
250 ## - EDITION STATEMENT |
Edition statement |
7th edition |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Bethesda, MD : |
Name of producer, publisher, distributor, manufacturer |
American Society of Health-System Pharmacists, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2022] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
©2022 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xxiv, 552 pages ; |
Dimensions |
26 cm + |
Accompanying material |
1 workbook (116 pages ; 28 cm) |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index |
505 00 - FORMATTED CONTENTS NOTE |
Miscellaneous information |
Section 1. |
Title |
Basic concepts and special populations |
Miscellaneous information |
Chapter 1 |
Title |
Rational use of drug concentration measurements / |
Statement of responsibility |
John E. Murphy -- |
Miscellaneous information |
Chapter 2. |
Title |
Assessment of kidney function / |
Statement of responsibility |
Joanna Q. Hudson -- |
Miscellaneous information |
Chapter 3. |
Title |
Renal drug dosing concepts / |
Statement of responsibility |
Dean A. Van Loo and Thomas C. Dowling -- |
Miscellaneous information |
Chapter 4. |
Title |
Medication dosing in overweight and obese patients / |
Statement of responsibility |
Brian L. Erstad -- |
Miscellaneous information |
Chapter 5. |
Title |
Pharmacogenomic impacts on pharmacokinetics / |
Statement of responsibility |
Cheryl D. Cropp -- Chapter 6. |
Title |
Drug dosing in pediatric patients / |
Statement of responsibility |
Vinita B. Pai and Milap C. Nataha -- |
Miscellaneous information |
Chapter 7. |
Title |
Considerations for medication use in the geriatric patient / |
Statement of responsibility |
Susan W. Miller -- |
Miscellaneous information |
Section 2. |
Title |
Specific drugs and drug classes |
Miscellaneous information |
Chapter 8. |
Title |
Aminoglycosides / |
Statement of responsibility |
Kathryn R. Matthias and John E. Murphy. -- |
Miscellaneous information |
Chapter 9. |
Title |
Antidepressants / |
Statement of responsibility |
Patrick R. Finley. -- |
Miscellaneous information |
Chapter10. |
Title |
Antiepileptics / |
Statement of responsibility |
Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin. |
Miscellaneous information |
Chapter 11. |
Title |
Antirejection agents / |
Statement of responsibility |
Tony K.L. Kiang |
Miscellaneous information |
Chapter 12. |
Title |
Carbamazepine / |
Statement of responsibility |
Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin -- |
Miscellaneous information |
Chapter 13. |
Title |
Digoxin / |
Statement of responsibility |
Robert J. DiDomenico and Robert L. Page II -- |
Miscellaneous information |
Chapter 14. |
Title |
Ethosuximide / |
Statement of responsibility |
Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin -- |
Miscellaneous information |
Chapter 15. |
Title |
Unfractioned Heparin, low-molecular-weight heparins, and Fondaparinux / |
Statement of responsibility |
A. Joshua Roberts, Hahyoon Kim, and William E. Dager -- |
Miscellaneous information |
Chapter 16. |
Title |
Lidocaine / |
Statement of responsibility |
Toby C. Trujillo -- |
Miscellaneous information |
Chapter 17. |
Title |
Lithium / |
Statement of responsibility |
Tanya J. Fabian and Matthew A. Fuller -- |
Miscellaneous information |
Chapter 18. |
Title |
Phenobarbital / |
Statement of responsibility |
Kimberly B. Tallian and Douglas M. Anderson. -- |
Miscellaneous information |
Chapter 19. |
Title |
Phenytoin and Fosphenytoin / |
Statement of responsibility |
Wendy Chang and Tony K.L. Kiang -- |
Miscellaneous information |
Chapter 20. |
Title |
Theophylline / |
Statement of responsibility |
Catherine B. Hobart and Hanna Phan -- |
Miscellaneous information |
Chapter21. |
Title |
Valproate / |
Statement of responsibility |
Barry E Gidal -- |
Miscellaneous information |
Chapter 22. |
Title |
Vancomycin / |
Statement of responsibility |
Jeremiah J. Duby, Monica A. Donnelley, Chelsea L. Tasaka, and Brett H. Heinz -- |
Miscellaneous information |
Chapter 23. |
Title |
Warfarin / |
Statement of responsibility |
Sara R. Vazquez -- |
Miscellaneous information |
Appendix A. |
Title |
Therapeutic ranges of drugs in traditional and SI units -- |
Miscellaneous information |
Appendix B. |
Title |
Nondrug reference ranges from common laboratory tests in traditional and SI units |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"Written in a straightforward style, with numerous charts and lists, this reference + workbook makes complicated dosing and monitoring information easy to find and understand. Whether you are a student or practitioner, it is a resource you will turn to for reliable guidance throughout your pharmacy career...Clinical Pharmacokinetics, 7th Edition, includes the most current information, covering issues such as rational use of drug concentration measurements, changes in dosing obese patients, and considerations for a wider variety of drugs for special populations" -- Publisher's website |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacokinetics. |
Authority record control number |
http://id.loc.gov/authorities/subjects/sh85100597 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacokinetics |
Form subdivision |
Handbooks, manuals, etc |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacokinetics. |
Authority record control number |
https://id.nlm.nih.gov/mesh/D010599 |
655 #2 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Handbook |
655 #7 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Handbooks and manuals. |
Source of term |
fast |
Authority record control number |
(OCoLC)fst01423877 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Society of Health-System Pharmacists. |
Authority record control number |
http://id.loc.gov/authorities/names/no95010636 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |